Related Experiment Video

Updated: Jul 7, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and

E Marc Jolicoeur1, E Magnus Ohman, Robert Temple

  • 1Duke University, Durham, NC, USA. marc.jolicoeur@duke.edu

American Heart Journal
|February 26, 2008
PubMed

Insights

Advanced coronary artery disease (CAD) affects a growing patient population, yet research and treatment options remain limited. This review examines the current understanding, therapeutic limitations, and challenges in developing new treatments for advanced CAD.

Area of Science:

  • Cardiology
  • Atherosclerosis Research

Background:

  • The prevalence of advanced coronary artery disease (CAD) is increasing due to an aging population and improved survival rates from atherosclerosis treatments.
  • Patients with symptomatic advanced CAD often have limited options for angina relief, despite the growing number of affected individuals.
  • Advanced CAD is under-recognized, with poorly defined scope, limited guideline coverage, and a scarcity of novel therapeutic options.

Purpose of the Study:

  • To review the current understanding of advanced coronary artery disease (CAD).
  • To discuss the limitations of existing therapies for advanced CAD.
  • To identify challenges and barriers in developing new treatments for this patient group.

Main Methods:

  • Expert consensus meeting held December 4-5, 2006.
  • Literature review of contemporary and emerging therapies for advanced CAD.
  • Analysis of the current status, therapeutic limits, and development barriers for advanced CAD treatments.

Main Results:

  • The scope of advanced CAD is not well-defined, and professional guidelines offer limited coverage.
  • Contemporary therapies for advanced CAD have limitations in relieving symptoms and improving outcomes.
  • Significant difficulties and barriers hinder the development of new medical treatments for advanced CAD.

Conclusions:

  • There is a critical need for increased attention and research into advanced coronary artery disease.
  • Overcoming barriers in research and development is essential to provide better therapeutic options for patients with advanced CAD.
  • Further investigation into the understanding and treatment of advanced CAD is warranted to address the growing patient population.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...